CARMEL, Ind., Sept. 26, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies that ...
CARMEL, Ind., Aug. 22, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (NYSE American: NRXS), (“NeurAxis,” or the “Company”), a medical technology company commercializing neuromodulation therapies that ...
BOSTON--(BUSINESS WIRE)--In recognition of Veterans Day, AcuityMD announces its partnership with Electromedical Products International (EPI) to drive access to Alpha-Stim ®, a non-invasive, ...
MINERAL WELLS, Texas--(BUSINESS WIRE)--Pulvinar Neuro, a wholly owned subsidiary of Electromedical Products International, Inc. (EPI) developing non-invasive brain stimulation devices, was awarded a ...
Brain stimulation therapy is a category of procedures in which electrodes or magnets, usually placed on the scalp or inserted into the brain, are used to treat some neurological disorders or serious ...
NeurAxis, Inc. has announced new medical policy coverage for its Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, specifically the IB-Stim device, by two health insurers in ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved an expanded indication of Boston Scientific’s spinal cord stimulation system that treats ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results